These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6240431)

  • 1. Monoclonal antibody-defined B cell subsets in aging humans and Down's syndrome.
    Gupta S; Zola H; Brooks DA; Bradley J; Fikrig SM; Mariano E; Quazi Q
    Gerontology; 1984; 30(6):388-92. PubMed ID: 6240431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.
    Gupta S; Fikrig SM; Mariano E; Quazi Q
    Clin Exp Immunol; 1983 Jul; 53(1):25-30. PubMed ID: 6223734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T and B lymphocytes in patients with Down's syndrome.
    Reiser K; Whitcomb C; Robinson K; MacKenzie MR
    Am J Ment Defic; 1976 May; 80(6):613-9. PubMed ID: 134638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 21 (Down's syndrome): autoimmunity, aging and monoclonal antibody-defined T-cell abnormalities.
    Rabinowe SL; Rubin IL; George KL; Adri MN; Eisenbarth GS
    J Autoimmun; 1989 Feb; 2(1):25-30. PubMed ID: 2526634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects.
    Chiricolo M; Minelli L; Licastro F; Tabacchi P; Zannotti M; Franceschi C
    Gerontology; 1984; 30(3):145-52. PubMed ID: 6233207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell response to anti-CD3 antibody in Down's syndrome.
    Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
    Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients.
    Singh VK; Fudenberg HH; Brown FR
    Mech Ageing Dev; 1986-1987 Jan; 37(3):257-64. PubMed ID: 2952844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes.
    Brooks DA; Beckman IG; Bradley J; McNamara PJ; Thomas ME; Zola H
    J Immunol; 1981 Apr; 126(4):1373-7. PubMed ID: 6970772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte surface phenotypes in Down's syndrome.
    Bertotto A; Lungarotti MS; Gentili F; Vaccaro R
    Int J Tissue React; 1984; 6(3):219-21. PubMed ID: 6237071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T and B lypmhocyte subpopulations in Down's syndrome. A study on non-institutionalised subjects.
    Franceschi C; Licastro F; Paolucci P; Masi M; Cavicchi S; Zannotti M
    J Ment Defic Res; 1978 Sep; 22(3):179-91. PubMed ID: 151743
    [No Abstract]   [Full Text] [Related]  

  • 12. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.
    Licastro F; Chiricolo M; Tabacchi P; Barboni F; Zannotti M; Franceschi C
    Cell Immunol; 1983 Jan; 75(1):111-21. PubMed ID: 6297805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic parameters in Down's syndrome.
    Jacobs PF; Burdash NM; Manos JP; Duncan RC
    Ann Clin Lab Sci; 1978; 8(1):17-22. PubMed ID: 146453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome.
    Cossarizza A; Ortolani C; Forti E; Montagnani G; Paganelli R; Zannotti M; Marini M; Monti D; Franceschi C
    Blood; 1991 Mar; 77(6):1263-70. PubMed ID: 1825795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunological profile of children with Down's syndrome].
    Colombo ML; Girardo E; Saitta M; Ricci BM; Maina D
    Minerva Pediatr; 1989 Jan; 41(1):1-4. PubMed ID: 2525223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphocyte subpopulations in Down's syndrome].
    Mori M; Zaike Y; Takeda T
    Rinsho Ketsueki; 1986 Oct; 27(10):1829-33. PubMed ID: 2950258
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential expression of lymphocyte function-associated antigen (LFA-1) on peripheral blood leucocytes from individuals with Down's syndrome.
    Barrena MJ; Echaniz P; Garcia-Serrano C; Zubillaga P; Cuadrado E
    Clin Exp Immunol; 1992 Apr; 88(1):41-4. PubMed ID: 1348667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective monocyte chemotaxis in children with Down's syndrome.
    Barroeta O; Nungaray L; López-Osuna M; Armendares S; Salamanca F; Kretschmer RR
    Pediatr Res; 1983 Apr; 17(4):292-5. PubMed ID: 6222283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
    Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
    Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.